Table 3.

Clinical Outcome of HSVE after Neurosurgery

		Death or sequelae
Overall		14/26 (53.8 %)
	Children	4/7 (57.1 %)
	Adults	10/19 (52.6 %)
No treatmenta		5/5 (100.0 %)
Treatment		9/21 (42.9 %)
	Initiatied ≤ 2 daysb	0/5 (0.0 %)
	Initiated ≥ 3 daysb	8/14 (57.1 %)

^aidoxuridine considered as “no treatment”

^b2 reports excluded as timing of treatment is not indicated [5, 10]